[1] Biller LH, Schrag D, 2021, Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA, 325(7): 669-685.
[2] Gandini A, Taieb J, Blons H, et al., 2024, Early-Onset Colorectal Cancer: From the Laboratory to the Clinic. Cancer Treatment Reviews, 130: 102821.
[3] Warburg O, Wind F, Negelein E, 1927, The Metabolism of Tumors in the Body. Journal of General Physiology, 8(6): 519-530.
[4] An J, Zhang LM, Duan Y, et al., 2026, Sodium's Role and Therapeutic Targeting in Cancer. Trends in Pharmacological Sciences, 47(1): 53-65.
[5] Brooks GA, 2018, The Science and Translation of Lactate Shuttle Theory. Cell Metabolism, 27(4): 757-785.
[6] Zhang L, Xin C, Wang S, et al., 2024, Lactate Transported by MCT1 Plays an Active Role in Promoting Mitochondrial Biogenesis and Enhancing TCA Flux in Skeletal Muscle. Science Advances, 10(26): eadn4508.
[7] Li Y, Zhang R, Hei H, 2023, Advances in Post-Translational Modifications of Proteins and Cancer Immunotherapy. Frontiers in Immunology, 14: 1229397.
[8] Zhang D, Tang Z, Huang H, et al., 2019, Metabolic Regulation of Gene Expression by Histone Lactylation. Nature, 574(7779): 575-580.
[9] He Y, Song T, Ning J, et al., 2024, Lactylation in Cancer: Mechanisms in Tumour Biology and Therapeutic Potentials. Clinical and Translational Medicine, 14(11): e70070.
[10] Zhong X, He X, Wang Y, et al., 2022, Warburg Effect in Colorectal Cancer: The Emerging Roles in Tumor Microenvironment and Therapeutic Implications. Journal of Hematology & Oncology, 15(1): 160.
[11] Yang Y,  Wu Y, Chen H, et al., 2025, Research Progress on the Interaction Between Glucose Metabolic Reprogramming and Lactylation in Tumors. Frontiers in Immunology, 16: 1595162.
[12] Chen Q, Yang B, Liu X, et al., 2022, Histone Acetyltransferases CBP/p300 in Tumorigenesis and CBP/p300 Inhibitors as Promising Novel Anticancer Agents. Theranostics, 12(11): 4935-4948.
[13] Varner EL, Trefely S, Bartee D, et al., 2020, Quantification of Lactoyl-CoA (Lactyl-CoA) by Liquid Chromatography Mass Spectrometry in Mammalian Cells and Tissues. Open Biology, 10(9): 200187.
[14] Wei J, Ding Q, Wang H, et al., 2025, Lactylation in Digestive System Tumors: From Mechanisms to Therapeutic Target. Frontiers in Oncology, 15: 1607249.
[15] Li H, Liu C, Li R, et al., 2024, AARS1 and AARS2 Sense L-Lactate to Regulate cGAS as Global Lysine Lactyltransferases. Nature, 634(8036): 1229-1237.
[16] Gaffney DO, Jennings EQ, Anderson CC, et al., 2020, Non-Enzymatic Lysine Lactoylation of Glycolytic Enzymes. Cell Chemical Biology, 27(2): 206-213.e6.
[17] Ansari A, Rahman MS, Saha SK, et al., 2017, Function of the SIRT3 Mitochondrial Deacetylase in Cellular Physiology, Cancer, and Neurodegenerative Disease. Aging Cell, 16(1): 4-16.
[18] Xie B, Zhang M, Li J, et al., 2024, KAT8-Catalyzed Lactylation Promotes eEF1A2-Mediated Protein Synthesis and Colorectal Carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America, 121(8): e2314128121.
[19] Milazzo G, Mercatelli D, Di Muzio G, et al., 2020, Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. Genes, 11(5): 556.
[20] Jennings EQ, Ray JD, Zerio CJ, et al., 2021, Sirtuin 2 Regulates Protein LactoylLys Modifications. ChemBioChem, 22(12): 2102-2106.
[21] Chen Y, Zhou Y, Yin H, 2021, Recent Advances in Biosensor for Histone Acetyltransferase Detection. Biosensors and Bioelectronics, 175: 112880.
[22] Fan H, Yang F, Xiao Z, et al., 2023, Lactylation: Novel Epigenetic Regulatory and Therapeutic Opportunities. American Journal of Physiology-Endocrinology and Metabolism, 324(4): E330-E338.
[23] Yang Z, Yan C, Ma J, et al., 2023, Lactylome Analysis Suggests Lactylation-Dependent Mechanisms of Metabolic Adaptation in Hepatocellular Carcinoma. Nature Metabolism, 5(1): 61-79.
[24] Wang T, et al., 2023, Lactate-Induced Protein Lactylation: A Bridge Between Epigenetics and Metabolic Reprogramming in Cancer. Cell Proliferation, 56(10): e13478.
[25] Deng J, Ye Z, Li Z, Jing DS, et al., 2025, Histone Lactylation Enhances GCLC Expression and Thus Promotes Chemoresistance of Colorectal Cancer Stem Cells Through Inhibiting Ferroptosis. Cell Death & Disease, 16(1): 193.
[26] Li W, Zhou C, Yu L, et al., 2024, Tumor-Derived Lactate Promotes Resistance to Bevacizumab Treatment by Facilitating Autophagy Enhancer Protein RUBCNL Expression Through Histone H3 Lysine 18 Lactylation (H3K18la) in Colorectal Cancer. Autophagy, 20(1): 114-130.
[27] Zhang L, Zhang F, Liang H, et al., 2025, Hippo/YAP Signaling Pathway in Colorectal Cancer: Regulatory Mechanisms and Potential Drug Exploration. Frontiers in Oncology, 15: 1545952.
[28] Chen P, Gao YH, Xie SX, et al., 2026, Lactylation in Colorectal Cancer: From Mechanism to Clinical Application. Biochemical Pharmacology, 244: 117621.
[29] Zhou J, Xu W, Wu Y, et al., 2023, GPR37 Promotes Colorectal Cancer Liver Metastases by Enhancing the Glycolysis and Histone Lactylation via Hippo Pathway. Oncogene, 42(45): 3319-3330.
[30] Mateyak MK, Kinzy TG, 2010, eEF1A: Thinking Outside the Ribosome. Journal of Biological Chemistry, 285(28): 21209-21213.
[31] Abbas W, Kumar A, Herbein G, 2015, The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections. Frontiers in Oncology, 5: 75.
[32] Cheng Z, Huang H, Li M, et al., 2024, Proteomic Analysis Identifies PFKP Lactylation in SW480 Colon Cancer Cells. iScience, 27(1): 108645.
[33] Chu YD, Cheng LC, Lim SN, et al., 2023, Aldolase B-Driven Lactagenesis and CEACAM6 Activation Promote Cell Renewal and Chemoresistance in Colorectal Cancer Through the Warburg Effect. Cell Death & Disease, 14(10): 660.
[34] Xiong J, Cai X, Wu F, et al., 2022, Lactylation-Driven METTL3-Mediated RNA m(6)A Modification Promotes Immunosuppression of Tumor-Infiltrating Myeloid Cells. Molecular Cell, 82(9): 1660-1677.e10.
[35] Liu S, Ma Q, Zeng C, et al., 2025, Crosstalk Between Lactylation and RNA Modifications in Tumorigenesis: Mechanisms and Therapeutic Implications. Biomarker Research, 13(1): 110.
[36] Sun L, Zhang Y, Yang B, et al., 2023, Lactylation of METTL16 Promotes Cuproptosis via m(6)A-Modification on FDX1 mRNA in Gastric Cancer. Nature Communications, 14(1): 6523.
[37] Stacpoole PW, Dirain CO, 2024, The Pyruvate Dehydrogenase Complex at the Epigenetic Crossroads of Acetylation and Lactylation. Molecular Genetics and Metabolism, 143(1-2): 108540.
[38] Zhang C, Yu R, Li S, Yuan M, et al., 2025, KRAS Mutation Increases Histone H3 Lysine 9 Lactylation (H3K9la) to Promote Colorectal Cancer Progression by Facilitating Cholesterol Transporter GRAMD1A Expression. Cell Death & Differentiation, 32(12): 2225-2238.
[39] Li DD, Tang Y L, Wang X, 2023, Challenges and Exploration for Immunotherapies Targeting Cold Colorectal Cancer. World Journal of Gastrointestinal Oncology, 15(1): 55-68.
[40] Wu B, Zhang B, Li B, et al., 2024, Cold and Hot Tumors: From Molecular Mechanisms to Targeted Therapy. Signal Transduction and Targeted Therapy, 9(1): 274.
[41] Miao Z, Zhao X, Liu X, 2023, Hypoxia Induced β-Catenin Lactylation Promotes the Cell Proliferation and Stemness of Colorectal Cancer Through the Wnt Signaling Pathway. Experimental Cell Research, 422(1): 113439.
[42] Gao J,  Liu R, Huang K, et al., 2025, Dynamic Investigation of Hypoxia-Induced L-Lactylation. Proceedings of the National Academy of Sciences of the United States of America, 122(10): e2404899122.
[43] Chen J, Huang Z, Chen Y, et al., 2025, Lactate and Lactylation in Cancer. Signal Transduction and Targeted Therapy, 10(1): 38.
[44] Dong Z, Yuan Z, Jin T, et al., 2025, Lactate at the Crossroads of Tumor Metabolism and Immune Escape: A New Frontier in Cancer Therapy. Journal of Translational Medicine, 23(1): 1239.
[45] Zhang C, Zhou L, Zhang M, et al., 2024, H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Research, 84(21): 3589-3601.
[46] Gou Z, Sun Q, Li J, 2025, Exploring Lactylation and Cancer Biology: Insights from Pathogenesis to Clinical Applications. Frontiers in Cell and Developmental Biology, 13: 1598232.
[47] Llibre A, Kucuk S, Gope A, et al., 2025, Lactate: A Key Regulator of the Immune Response. Immunity, 58(3): 535-554.
[48] Raychaudhuri D, Singh P, Chakraborty B, et al., 2024, Histone Lactylation Drives CD8+ T Cell Metabolism and Function. Nature Immunology, 25(11): 2140-2151.
[49] Li Q,  Zhao R, Shen Y, et al., 2025, Lactylation in Tumor Immune Escape and Immunotherapy: Multifaceted Functions and Therapeutic Strategies. Research, 8: 0793.
[50] Pugh CW, Ratcliffe PJ, 2003, Regulation of Angiogenesis by Hypoxia: Role of the HIF System. Nature Medicine, 9(6): 677-684.
[51] Guzy RD, Schumacker PT, 2006, Oxygen Sensing by Mitochondria at Complex III: The Paradox of Increased Reactive Oxygen Species During Hypoxia. Experimental Physiology, 91(5): 807-819.
[52] Vallée A, Guillevin R, Vallée JN, 2018, Vasculogenesis and Angiogenesis Initiation Under Normoxic Conditions Through Wnt/β-Catenin Pathway in Gliomas. Reviews in the Neurosciences, 29(1): 71-91.
[53] Végran F, Boidot R, Michiels C, et al., 2011, Lactate Influx Through the Endothelial Cell Monocarboxylate Transporter MCT1 Supports an NF-κB/IL-8 Pathway That Drives Tumor Angiogenesis. Cancer Research, 71(7): 2550-2560.
[54] Tang J, Ming L, Qin F, et al., 2024, The Heterogeneity of Tumour-Associated Macrophages Contributes to the Clinical Outcomes and Indications for Immune Checkpoint Blockade in Colorectal Cancer Patients. Immunobiology, 229(3): 152805.
[55] Xu B, Liu Y, Li N, et al., 2024, Lactate and Lactylation in Macrophage Metabolic Reprogramming: Current Progress and Outstanding Issues. Frontiers in Immunology, 15: 1395786.
[56] Hu H, Peng F, Ba Q, et al., 2025, Integrative Machine Learning Identifies Lactylation-Related Gene Signature Prognostic for Chemotherapeutic Efficacy in Colorectal Carcinoma. Discover Oncology, 17(1): 69.
[57] Jones AR, Siepen JA, Hubbard SJ, et al., 2009, Improving Sensitivity in Proteome Studies by Analysis of False Discovery Rates for Multiple Search Engines. Proteomics, 9(5): 1220-1229.
[58] Sun Y, Yang X, Kong F, et al., 2025, The Mechanisms and Effects of Lactylation Modification in Different Kinds of Cancers. Discover Oncology, 16(1): 560.
[59] Xing W, Li X, Zhou Y, et al., 2023, Lactate Metabolic Pathway Regulates Tumor Cell Metastasis and Its Use as a New Therapeutic Target. Exploration of Medicine, 4(4): 542-560.
[60] Wang Q, Yu Y, Zhuang J, et al., 2025, Demystifying the cGAS-STING Pathway: Precision Regulation in the Tumor Immune Microenvironment. Molecular Cancer, 24(1): 178.